Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cell Biology

Background:

• Cryopreservation is crucial for stem cell therapy, but high dimethyl sulfoxide (DMSO) concentrations pose risks.
• Hydrogel microcapsules have shown potential to improve cell survival during freezing.
• Current research often uses rapid freezing or high DMSO levels, limiting clinical safety.

Purpose of the Study:

• To investigate the impact of hydrogel microcapsules on mesenchymal stem cell (MSC) viability, phenotype, and function after cryopreservation.
• To evaluate the efficacy of low-concentration DMSO with microencapsulation for safer stem cell storage.
• To develop an optimized cryopreservation strategy for clinical stem cell applications.

Main Methods:

• Mesenchymal stem cells (MSCs) were encapsulated in hydrogel microcapsules.
• Microcapsules were cryopreserved using varying DMSO concentrations (0-10%).
• Cell viability, morphology, phenotype, gene expression, and differentiation potential were analyzed, particularly at 2.5% DMSO.

Main Results:

• Cryopreservation with 2.5% DMSO in microcapsules met the minimum 70% viability requirement for clinical use.
• Hydrogel microencapsulation preserved MSC phenotype and differentiation potential.
• Microencapsulation improved MSC viability compared to standard cryopreservation methods at low DMSO concentrations.

Conclusions:

• Hydrogel microencapsulation enables reduced DMSO concentrations for stem cell cryopreservation.
• This technology mitigates cryoinjury, enhancing cell survival and quality.
• Encapsulated cell-biomaterial constructs offer a promising strategy for efficient stem cell storage and clinical translation.